Advanz Pharma is fined for substantially hiking the price of a generic drug.

When it comes to conducting clinical trials in emerging geographies, there are four key challenges to consider.

It was by serendipity that Hendrik Dietz learned how to make a virus trap. Now, his team may be sitting on a new way to combat disease.

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

The EMA releases its annual report highlighting its achievements throughout 2020.

Global regulators attended a virtual workshop on second generation COVID-19 vaccines – here’s what they talked about.

We sit down to interview Peter Marks, Director of the Center for Biologics Evaluation and Research at the US FDA.

Bringing customized medicines to patients with additive manufacturing.

How can pharma make the most of digital technologies?

GSK forms strategic partnership with Alector to produce monoclonal antibodies for neurodegenerative diseases.